Complement Therapeutics
Munich, DE · 4 known investors
Complement Therapeutics is a clinical-stage biotechnology company developing gene therapies for complement-mediated diseases, with a lead AAV-based candidate (CTx001) for Geographic Atrophy secondary to Age-related Macular Degeneration. A University of Manchester spinout, it runs clinical and natural history studies in ophthalmology across the US and UK.
BiotechDigital HealthHealthtechMedical Devices
Founders & leadership
RH
Rafiq HasanCEO and Managing Director
MA
Muhammad Ali MemonChief Medical Officer